The diagnosis of renal carcinoma with SMARCB1 deficiency remains challenging due to the rarity of this neoplasm and the nonspecific initial symptoms, which may mimic lower urinary tract diseases. This evidence concerns the gene SMARCB1 and renal carcinoma.